These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33515704)

  • 21. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of O-GlcNAcylation is important for pig preimplantation development.
    Shibutani M; Mori T; Miyano T; Miyake M
    J Reprod Dev; 2015; 61(4):341-50. PubMed ID: 26004176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. '
    Zhao L; Shah JA; Cai Y; Jin J
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein O-GlcNAcylation in cardiovascular diseases.
    Wang HF; Wang YX; Zhou YP; Wei YP; Yan Y; Zhang ZJ; Jing ZC
    Acta Pharmacol Sin; 2023 Jan; 44(1):8-18. PubMed ID: 35817809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
    Love DC; Hanover JA
    Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcylation, a sweet link to the pathology of diseases.
    Nie H; Yi W
    J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The non-catalytic domains of O-GlcNAc cycling enzymes present new opportunities for function-specific control.
    Hu CW; Wang K; Jiang J
    Curr Opin Chem Biol; 2024 Aug; 81():102476. PubMed ID: 38861851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acutely elevated O-GlcNAcylation suppresses hippocampal activity by modulating both intrinsic and synaptic excitability factors.
    Hwang H; Rhim H
    Sci Rep; 2019 May; 9(1):7287. PubMed ID: 31086206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
    Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
    J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
    Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
    Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. O-GlcNAc signaling in cancer metabolism and epigenetics.
    Singh JP; Zhang K; Wu J; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
    Rahman MA; Hwang H; Cho Y; Rhim H
    Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.
    Singh JP; Qian K; Lee JS; Zhou J; Han X; Zhang B; Ong Q; Ni W; Jiang M; Ruan HB; Li MD; Zhang K; Ding Z; Lee P; Singh K; Wu J; Herzog RI; Kaech S; Wendel HG; Yates JR; Han W; Sherwin RS; Nie Y; Yang X
    Oncogene; 2020 Jan; 39(3):560-573. PubMed ID: 31501520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional significance of O-linked N-acetylglucosamine protein modification in regulating autophagy.
    Zhu Z; Ren W; Li S; Gao L; Zhi K
    Pharmacol Res; 2024 Apr; 202():107120. PubMed ID: 38417774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ac
    Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
    Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation.
    Mitchell CW; Galan Bartual S; Ferenbach AT; Scavenius C; van Aalten DMF
    Glycobiology; 2023 Dec; 33(12):1172-1181. PubMed ID: 37856504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.